Humana upgraded to Buy from Hold at Deutsche Bank

As previously reported, Deutsche Bank upgraded Humana (HUM) to Buy from Hold with a price target of $441, up from $235. The firm upgraded three managed care names citing a stabilizing managed care market. For Humana, the analyst expects the company’s Medicare star ratings to recover. 2026 should be the earnings bottom for Humana and a rebasing year depending on stars results in October, the analyst tells investors in a research note.